SearchDictionaryMobileLogin

Anoxia (Hypoxia)

39565  relevant articles (1351 outcomes, 4166 trials/studies) found for this Disease

Description: Relatively complete absence of oxygen in one or more tissues.

Also Known As:
Hypoxia; Hypoxemia; Anoxemia; Deficiency, Oxygen; Anoxemias; Anoxias; Deficiencies, Oxygen; Hypoxemias; Hypoxias; Oxygen Deficiencies; Oxygen Deficiency

Relationship Network

Disease Context: Research Results

Related Diseases

1. Ischemia
2. Neoplasms (Cancer)
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Anoxia (Hypoxia)
5. Hypercapnia

Experts

1. Harris, Adrian L: 33 articles (06/2008 - 03/2002)
2. Delivoria-Papadopoulos, Maria: 27 articles (08/2008 - 01/2002)
3. Harris, A L: 25 articles (07/2008 - 06/2000)
4. Mishra, O P: 23 articles (09/2006 - 01/2000)
5. Semenza, Gregg L: 22 articles (12/2008 - 01/2002)
6. Mishra, Om P: 22 articles (08/2008 - 01/2002)
7. Delivoria-Papadopoulos, M: 20 articles (09/2006 - 01/2000)
8. Gozal, David: 18 articles (07/2008 - 09/2002)
9. Eltzschig, Holger K: 17 articles (08/2008 - 10/2002)
10. Ratcliffe, Peter J: 16 articles (06/2008 - 01/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Anoxia:
1. OxygenIBA
11/01/2009 - "We found that (1) in contrast to oxygen partial pressure in blood (P(a)O(2)), the baseline value of P(t)O(2) in summer euthermic AGS is significantly higher than in rats; (2) both P(t)O(2) and P(a)O(2) are dramatically reduced by inspired 8% O(2) in AGS and rats, but AGS have a greater capacity in P(t)O(2) to cope with environmental hypoxia; (3) metabolic rate before, during, and after hypoxic exposure is consistently lower in AGS than in rats; (4) the respiratory responding patterns to hypoxia in the two species differ in that f(R) decreases in AGS but increases in rats. "
09/13/2004 - "Acute hypoxia reduced the median oxygen partial pressure (pO(2)) dramatically (1 vs 10 mmHg in controls), whereas in chronically hypoxic tumours the pO(2) was significantly improved (median pO(2)=4 mmHg), however not reaching the control level. "
07/04/1977 - "Portacaval transposition and end-to-side shunt led to a striking oxygen deficit of the liver tissue with no incidence of compensation by the hepatic artery; Oxygen supply was improved considerably by a side-to-side shunt and tissue hypoxia could be prevented by a mesenterico-caval shunt and splenocaval shunt. "
01/01/1995 - "Measurement of cardiac output and clinical assessment of the patients' oxygen requirements will complete the macro picture of supply and demand and although computed indicators of hypoxia have been improved in recent years (1, 2) the definitive diagnosis of histohypoxia requires the measurement of the cellular and subcellular products of metabolic processes that are present when an inappropriate concentration of oxygen has been experienced. "
09/24/1983 - "That the fall in oxygen saturation was significantly greater (p less than 0.05) in the obese non-responders suggests that central as well as mechanical factors may be important for the genesis of nocturnal hypoxia and is evidence for a disturbance of central nervous function in some obese women."
Order ALL the reference details at left...
2. Adenosine Triphosphate (ATP)IBA
3. Glucose (Dextrose)FDA LinkGeneric
4. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
5. Nitric Oxide (Nitrogen Monoxide)FDA Link
6. AdenosineFDA LinkGeneric
7. Carbon MonoxideIBA
8. Lactic AcidFDA LinkGeneric
9. Glutamic Acid (Glutamate)FDA Link
10. CalciumIBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Positive-Pressure Respiration (PEEP)
3. Artificial Respiration (Mechanical Ventilation)
4. Resuscitation
5. Extracorporeal Membrane Oxygenation (ECMO)

Best Treatments:
Research Summary Report
on Anoxia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1351 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>